drugset / Trial / NCT01473277
Botulinum Toxin Type A (BT-A) in Hemiplegic Shoulder Pain Versus Steroid
Phase 2
Unknown
52 enrolled
The Foundation Institute San Raffaele G. Giglio of Cefalù
Azienda Ospedaliero, Universitaria Pisana · collabFondazione Salvatore Maugeri · collabIRCCS San Camillo, Venezia, Italy · collabOspedale di Brunico · collabUniversità degli Studi di Ferrara · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
The aim of this study is to confirm the efficacy and safety of the intra-articular injection of BT-A in a multicentric double blind randomised study. For this purpose intra-articular injection of BT-A will be compared with the intra-articular steroid injection that is the current "gold standard" for the treatment of HSP.
Timeline
- Start
- 2012-01
- Primary completion
- 2012-06
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Botulinum toxin type A | Protein / enzyme biologic | 500 iu | Other |
| Comparator | Triamcinolone Acetonide | Other / unclassified | 40 mg | Other |